What is the difference between magnesium glycinate and magnesium citrate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Magnesium Glycinate vs. Magnesium Citrate: Key Differences

Magnesium citrate demonstrates superior bioavailability compared to magnesium glycinate and other magnesium formulations, with the strongest evidence showing greater serum magnesium levels and urinary excretion after supplementation 1.

Bioavailability and Absorption

The most definitive evidence comes from a randomized, double-blind study comparing magnesium preparations. Magnesium citrate achieved the highest mean serum magnesium concentration after both acute (24 hours) and chronic (60 days) supplementation compared to other forms including amino-acid chelate (which includes glycinate) 1. Specifically:

  • Magnesium citrate led to significantly greater serum Mg levels after acute supplementation (p=0.026) and chronic supplementation (p=0.006)
  • After 60 days, magnesium citrate resulted in the highest salivary Mg concentration (p=0.027)
  • Both citrate and amino-acid chelate showed greater 24-hour urinary magnesium excretion than magnesium oxide (p=0.033), indicating superior absorption 1

A more recent 2024 study comparing various magnesium forms found that magnesium citrate increased muscle and brain magnesium levels in a dose-independent manner, though magnesium glycinate showed more modest effects 2.

Clinical Applications

For Constipation

Only magnesium oxide has been evaluated in clinical trials for chronic idiopathic constipation—the bioavailability and clinical efficacy of magnesium citrate and glycinate for constipation are unknown 3. This is a critical knowledge gap, as the osmotic laxative effect depends on poorly absorbed magnesium creating an osmotic gradient in the GI tract.

For Magnesium Repletion

In patients with documented hypomagnesemia (urine magnesium <70 mg/day), magnesium supplementation (250-500 mg/day elemental magnesium) significantly increased both urinary magnesium and citrate excretion, with 88% of supplemented patients achieving adequate magnesium levels versus only 58% with dietary approaches alone 4.

Tolerability Differences

Magnesium citrate has a well-established laxative effect, which can be therapeutic for constipation but problematic for magnesium repletion. In contrast, magnesium glycinate (as part of amino-acid chelate formulations) was better tolerated in patients with ileal resection, causing less cathartic action while maintaining absorption 5.

A 2024 study of microencapsulated magnesium showed reduced adverse effects (intestinal motility, gastric heaviness) compared to non-encapsulated forms 6, though this technology isn't standard for either citrate or glycinate.

Mechanism of Absorption

The key mechanistic difference:

  • Magnesium citrate: Absorbed primarily via passive paracellular mechanisms enhanced by solvent drag; the citrate component itself increases urinary citrate (beneficial for kidney stone prevention) 4
  • Magnesium glycinate: Evidence suggests some portion may be absorbed intact as a dipeptide via active transport pathways in the proximal small intestine 5, potentially bypassing issues with distal intestinal disease

Practical Recommendations

Choose magnesium citrate when:

  • Constipation is present or desired
  • Kidney stone prevention is needed (increases urinary citrate)
  • Maximum bioavailability is the priority
  • Normal GI function exists

Choose magnesium glycinate when:

  • GI tolerance is a concern (less laxative effect)
  • Patient has malabsorption or short bowel syndrome
  • Magnesium repletion without bowel stimulation is needed
  • Patient cannot tolerate the laxative effects of citrate

Critical Caveats

  • Avoid all magnesium supplements in patients with creatinine clearance <20 mL/dL due to hypermagnesemia risk 3
  • Typical supplementation doses are 250-500 mg/day elemental magnesium 4
  • Dividing high doses (>400 mg) into twice-daily administration does NOT improve tissue magnesium levels compared to single daily dosing 2
  • Most magnesium salts are poorly absorbed and may worsen diarrhea in patients with high ostomy output 7

The evidence clearly favors magnesium citrate for bioavailability but magnesium glycinate for GI tolerability, making the choice dependent on the clinical indication and patient's GI function.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.